HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Free cash flow 2019–2025
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$347.9MFY2025 · since FY2019: -$75.6M → $347.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $347.9M | +59.1% |
| FY2024 | $218.7M | -0.2% |
| FY2023 | $219.1M | +51.8% |
| FY2022 | $144.3M | +46.9% |
| FY2021 | $98.3M | +3389.6% |
| FY2020 | -$3.0M | +96.0% |
| FY2019 | -$75.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HRMY financial trends
HRMY RevenueHRMY Net incomeHRMY Net marginHRMY Gross profitHRMY Gross marginHRMY Operating incomeHRMY Operating marginHRMY Operating cash flowHRMY Capital expendituresHRMY Return on equityHRMY Stock buybacksHRMY Dividends paidHRMY Total assetsHRMY Total liabilitiesHRMY Shareholders’ equityHRMY overview →